Chronic inflammation, driven by conditions like type two diabetes and hyperinsulinemia, can lead to various cancers through elevated blood sugar and systemic inflammation markers. Despite differing origins, many cancers exhibit similar dysregulated growth patterns, all linked to a common metabolic shift towards fermentation. Understanding this connection is crucial for effective cancer management, emphasizing the role of mitochondrial dysfunction in the disease's progression.
